WeVote
Log In

Bill

Bill

S 4545

Repeals section 2307 of the public health law relating to persons knowing themselves to be infected with venereal disease

2025 Regular Session Introduced by Jabari Brisport and 8 co-sponsors

Expands emergency epinephrine delivery by allowing single unit dose devices (eg nasal spray) beyond auto-injectors, and extends coverage to schools, colleges, and camps.

ORDERED TO THIRD READING RULES CAL.770
0
WeVote Research Nonpartisan
Bill Summary · S 4545

Summary — S-4545 (New Jersey)

Short title / Purpose

S-4545 updates New Jersey law that governs emergency administration of epinephrine by removing a requirement that epinephrine be given only via a pre‑filled auto‑injector and replacing that language with “single unit dose epinephrine mechanism.” The change expands permitted emergency epinephrine delivery options (explicitly including epinephrine nasal spray and allowing future technologies) and extends the revised provisions to schools, institutions of higher education, and youth camps.

Key sponsors

  • Sponsors: Sen. Michael L. Testa, Jr.; Sen. Shirley K. Turner
  • Co-sponsors: Senators Burgess, Henry, Gopal, Mukherji

Main provisions / What the bill does

  • Replaces specific references to pre‑filled auto‑injector mechanisms in current statute with the broader term “single unit dose epinephrine mechanism.”
  • Removes language limiting administration to an “FDA approved mechanism” and instead authorizes use of single‑unit dose products.
  • Explicitly expands the settings covered by the statute from K–12 schools to also include institutions of higher education and youth camps.
  • By using broader language, the bill explicitly permits epinephrine nasal spray and other single‑dose delivery technologies that may be developed in the future for emergency use (e.g., during anaphylactic reactions).

Who is affected

  • Students, faculty, staff and visitors at K–12 schools, college/university campuses, and youth camps.
  • School districts, higher‑education institutions, and camp operators (policies, procurement, and training).
  • School/nurse and non‑medical staff who may be authorized or trained to administer emergency epinephrine.
  • State/local public health authorities that provide guidance or oversight of emergency medication policies.

Potential impacts and considerations

  • Increases flexibility for emergency epinephrine stock and may improve access (e.g., for persons who cannot use or for institutions seeking alternatives to auto‑injectors).
  • May require updates to institutional policies, standing orders, training materials, procurement practices, and storage protocols.
  • Could affect costs and supply choices (different devices/products may have differing prices and shelf lives).
  • May prompt review of legal/liability language and medical standing orders to reflect allowed mechanisms.

Procedural status and history (selected)

  • Introduced: 2025-06-02; referred to Senate Health, Human Services & Senior Citizens Committee.
  • Reported out of committee with amendments: 2025-11-13.
  • Passed Senate: 2025-06-12; delivered to Assembly and referred to Codes.
  • Ordered to third reading (Rules Cal.770): status noted.

Related / companion bills

  • A6008 (companion)
  • A733 / A733A (companion/substituted)
  • S4603 (prior session)

Note: Committee amendments broadened the bill’s scope to include institutions of higher education and youth camps and substituted the phrase “single unit dose epinephrine mechanism” for previous phrasing referencing auto‑injectors or FDA‑approved mechanisms.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.